Objective: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer.
Outcomes: Outcomes of interest included prevention of morbidity and mortality from hemorrhage, effects on survival, quality of life, toxicity reduction, and cost-effectiveness.
Evidence: A complete MedLine search was performed of the past 20 years of the medical literature.